Evidence map›Paper›PMID 25934858›Full record

ArticleNeurology2015

Hospital costs of ischemic stroke and TIA in the Netherlands.

Leander R Buisman, Siok Swan Tan, Paul J Nederkoorn, Peter J Koudstaal, William K Redekop

Open access · greenAbstract read
In one paragraph

Article in Neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Leander R BuismanFrom the Institute of Health Policy and Management (L.R.B., S.S.T., W.K.R.) and the Institute for Medical Technology Assessment (L.R.B., S.S.T., W.K.R.), Erasmus University Rotterdam; the Department of Neurology (P.J.N.), Academic Medical Center, University of Amsterdam; and the Department of Neurology (P.J.K.), Erasmus MC, University Medical Center Rotterdam, the Netherlands. buisman@bmg.eur.nl.
Siok Swan TanFrom the Institute of Health Policy and Management (L.R.B., S.S.T., W.K.R.) and the Institute for Medical Technology Assessment (L.R.B., S.S.T., W.K.R.), Erasmus University Rotterdam; the Department of Neurology (P.J.N.), Academic Medical Center, University of Amsterdam; and the Department of Neurology (P.J.K.), Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Paul J NederkoornFrom the Institute of Health Policy and Management (L.R.B., S.S.T., W.K.R.) and the Institute for Medical Technology Assessment (L.R.B., S.S.T., W.K.R.), Erasmus University Rotterdam; the Department of Neurology (P.J.N.), Academic Medical Center, University of Amsterdam; and the Department of Neurology (P.J.K.), Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Peter J KoudstaalFrom the Institute of Health Policy and Management (L.R.B., S.S.T., W.K.R.) and the Institute for Medical Technology Assessment (L.R.B., S.S.T., W.K.R.), Erasmus University Rotterdam; the Department of Neurology (P.J.N.), Academic Medical Center, University of Amsterdam; and the Department of Neurology (P.J.K.), Erasmus MC, University Medical Center Rotterdam, the Netherlands.
William K RedekopFrom the Institute of Health Policy and Management (L.R.B., S.S.T., W.K.R.) and the Institute for Medical Technology Assessment (L.R.B., S.S.T., W.K.R.), Erasmus University Rotterdam; the Department of Neurology (P.J.N.), Academic Medical Center, University of Amsterdam; and the Department of Neurology (P.J.K.), Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Academic Medical Center · NLUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThere have been no ischemic stroke costing studies since major improvements were implemented in stroke care. We therefore determined hospital resource use and costs of ischemic stroke and TIA in the Netherlands for 2012.

methodsWe conducted a retrospective cost analysis using individual patient data from a national diagnosis-related group registry. We analyzed 4 subgroups: inpatient ischemic stroke, inpatient TIA, outpatient ischemic stroke, and outpatient TIA. Costs of carotid endarterectomy and costs of an extra follow-up visit were also estimated. Unit costs were based on reference prices from the Dutch Healthcare Insurance Board and tariffs provided by the Dutch Healthcare Authority. Linear regression analysis was used to examine the association between hospital costs and various patient and hospital characteristics.

resultsA total of 35,903 ischemic stroke and 21,653 TIA patients were included. Inpatient costs were €5,328 ($6,845) for ischemic stroke and €2,470 ($3,173) for TIA. Outpatient costs were €495 ($636) for ischemic stroke and €587 ($754) for TIA. Costs of carotid endarterectomy were €6,836 ($8,783). Costs of inpatient days were the largest contributor to hospital costs. Age, hospital type, and region were strongly associated with hospital costs.

conclusionsHospital costs are higher for inpatients and ischemic strokes compared with outpatients and TIAs, with length of stay (LOS) the most important contributor. LOS and hospital costs have substantially declined over the last 10 years, possibly due to improved hospital stroke care and efficient integrated stroke services.

Indexed as

Hospital CostsAgedAged, 80 and overFemaleFollow-Up StudiesHumansIschemic Attack, TransientLength of StayMaleMiddle AgedNetherlandsRetrospective StudiesStroke

Identifiers

PMID25934858
PMCPMC4456655
OpenAlexW2060664721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.